Publications

ONdrugDelivery’s series of sponsored themed publications is steadily becoming established globally as an important and valuable source for those who need to know today’s drug delivery industry.

The series has been specifically designed, based on ONdrugDelivery’s deep knowledge and clear understanding of the science and business of drug delivery, to meet the needs of its readers, and therefore also the needs of those who contribute to it.

Each edition focuses on one specific topic within the field of drug delivery (see the 2006/7 schedule for details). The format is simple. A short introductory piece gives a rundown of important issues, general trends and recent development within the subject area. This is followed by articles and company profiles contributed by the issue sponsors.

ONdrugDelivery’s unique publications offer a valuable lead in two important ways:

  1. Our degree of topic specialisation is unmatched. Readers know, just from viewing the title of a given edition, whether it is or is not on a topic that they are interested in. Our September “Nasal Drug Delivery” edition might be important for one reader, while “Novel Biomaterials in Drug Delivery” in July is crucial for another, but the next reader could be looking out for our August issue on “Delivering Injectables”. When a topic of interest is identified, they can be sure that from start to finish the publication will be of value.
  1. The honest position on funding, which allows readers to assess the content accurately and thus adds real value, is refreshing. Readers appreciate knowing precisely where the publications’ funding is sourced – i.e. from its sponsors, whose logos adorn the front covers. This contrasts with the complex web of vague advertiser-publisher-reader relationships that exist around many other industry publications.

We believe that there should be a place for companies developing delivery systems and related technologies and services, to present themselves – alongside others competing in the same space – through arguably the most the readily accessible and useful media of all – detailed, well written, strictly edited and immaculately presented feature articles.

Those in the pharmaceutical and biotechnology sectors, whose role it is to seek novel delivery systems and pair these with their own companies' research and product development programmes, agree. These are our readers. They absolutely require this information from the delivery sector. Our publications fulfil this requirement absolutely.